BFRI — Biofrontera Cashflow Statement
0.000.00%
Last trade - 00:00- $8.09m
- $10.58m
- $34.07m
- 21
- 55
- 56
- 40
Annual cashflow statement for Biofrontera, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11 | -11 | -37.7 | -0.64 | -20.1 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -3.42 | 0.883 | 12 | -18.9 | -0.874 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -23.9 | -2.83 | -1.5 | 2.79 | -4.39 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -37.7 | -12.4 | -26.7 | -16.2 | -24.9 |
| Capital Expenditures | -0.538 | 0 | -0.011 | -0.038 | -0.005 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 25.9 | 0 | — | -5.12 | 0.624 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 25.4 | 0 | -0.011 | -5.16 | 0.619 |
| Financing Cash Flow Items | 2.9 | 4.4 | 0 | — | 21.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.4 | 13.2 | 43.2 | 14 | 8.41 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.12 | 0.825 | 16.5 | -7.33 | -15.9 |